Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2

View ORCID ProfileKatherine Laiton-Donato, View ORCID ProfileCarlos Franco-Muñoz, View ORCID ProfileDiego A. Álvarez-Díaz, Hector Alejandro Ruiz-Moreno, View ORCID ProfileJosé A. Usme-Ciro, View ORCID ProfileDiego Andrés Prada, View ORCID ProfileJhonnatan Reales-González, View ORCID ProfileSheryll Corchuelo, View ORCID ProfileMaría T. Herrera-Sepúlveda, View ORCID ProfileJulian Naizaque, Gerardo Santamaría, View ORCID ProfileJorge Rivera, View ORCID ProfilePaola Rojas, View ORCID ProfileJuan Hernández Ortiz, View ORCID ProfileAndrés Cardona, View ORCID ProfileDiana Malo, View ORCID ProfileFranklin Prieto-Alvarado, Fernando Ruiz Gómez, View ORCID ProfileMagdalena Wiesner, View ORCID ProfileMartha Lucia Ospina Martínez, View ORCID ProfileMarcela Mercado-Reyes
doi: https://doi.org/10.1101/2021.05.08.21256619
Katherine Laiton-Donato
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine Laiton-Donato
  • For correspondence: kdlaitond@unal.edu.co
Carlos Franco-Muñoz
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Franco-Muñoz
Diego A. Álvarez-Díaz
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego A. Álvarez-Díaz
Hector Alejandro Ruiz-Moreno
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José A. Usme-Ciro
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
2Centro de Investigación en Salud para el Trópico - CIST, Facultad de Medicina, Universidad Cooperativa de Colombia, Santa Marta, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José A. Usme-Ciro
Diego Andrés Prada
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego Andrés Prada
Jhonnatan Reales-González
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jhonnatan Reales-González
Sheryll Corchuelo
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sheryll Corchuelo
María T. Herrera-Sepúlveda
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María T. Herrera-Sepúlveda
Julian Naizaque
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julian Naizaque
Gerardo Santamaría
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Rivera
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jorge Rivera
Paola Rojas
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paola Rojas
Juan Hernández Ortiz
3Laboratorio Genómico One Health. Medellín, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan Hernández Ortiz
Andrés Cardona
3Laboratorio Genómico One Health. Medellín, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrés Cardona
Diana Malo
4Dirección de Vigilancia en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diana Malo
Franklin Prieto-Alvarado
4Dirección de Vigilancia en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Franklin Prieto-Alvarado
Fernando Ruiz Gómez
5Ministerio de Salud y Protección Social de Colombia. Bogotá Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Wiesner
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Magdalena Wiesner
Martha Lucia Ospina Martínez
6Dirección General, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martha Lucia Ospina Martínez
Marcela Mercado-Reyes
1Group Genomics of Emerging Microorganisms. Dirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcela Mercado-Reyes
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

The genetic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, representative samples from circulating SARS-CoV-2 in Colombia between January and April 2021, were processed for genome sequencing and lineage determination following the nanopore amplicon ARTIC network protocol and PANGOLIN pipeline. This strategy allowed us to identify the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several substitutions affecting the Spike protein, including the amino acid changes T95I, Y144T, Y145S and the insertion 146N in the N-terminal domain, R346K, E484K and N501Y in the Receptor-binding Domain (RBD) and P681H1 in the S1/S2 cleavage site of the Spike protein. The rapid increase in frequency and fixation in a relatively short time in Magdalena, Atlántico, Bolivar, Bogotá D.C, and Santander that were near the theoretical herd immunity suggests an epidemiologic impact. Further studies will be required to assess the biological and epidemiologic roles of the substitution pattern found in the B.1.621 lineage.

Highlights

  • Monitoring the emergence of new variants of SARS-CoV-2 in real time is a worldwide priority.

  • Emerging variants of SARS-CoV-2 may have high impact biological implications for public health

  • The SARS-CoV-2 B.1.621 variant of interest was characterized by several substitutions: T95I, Y144T, Y145S, ins146N, R346K, E484K, N501Y and P681H in spike protein.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Project CEMIN-4-2020 Instituto Nacional de Salud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Good morning, dear reviewers, the ethical considerations were clarified in the body of manuscript because it was approved by the ethics committee of the National Institute of Health of Colombia within the framework of the Cemin 4 project. The circulation of the new variant of SARS-CoV-2 has been disclosed nationwide with an official statement (attached) because my Institution is the national authority on public health. We are also waiting for the lineage assignment by the PANGOLIN tool: https://github.com/cov-lineages/pango-designation/issues/23 I kindly require the acceptance of the preprint as soon as possible for its scientific divulgation that includes genetic characterization. Thank you very much for your prompt response. Regards

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is available in GISAID database, the phylogenetic analysis is available in a microreact site https://microreact.org/project/5CAiK3qCMaEgE4vYkKVpZW/b7113efc.

https://microreact.org/project/5CAiK3qCMaEgE4vYkKVpZW/b7113efc.

https://www.GISAID.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Katherine Laiton-Donato, Carlos Franco-Muñoz, Diego A. Álvarez-Díaz, Hector Alejandro Ruiz-Moreno, José A. Usme-Ciro, Diego Andrés Prada, Jhonnatan Reales-González, Sheryll Corchuelo, María T. Herrera-Sepúlveda, Julian Naizaque, Gerardo Santamaría, Jorge Rivera, Paola Rojas, Juan Hernández Ortiz, Andrés Cardona, Diana Malo, Franklin Prieto-Alvarado, Fernando Ruiz Gómez, Magdalena Wiesner, Martha Lucia Ospina Martínez, Marcela Mercado-Reyes
medRxiv 2021.05.08.21256619; doi: https://doi.org/10.1101/2021.05.08.21256619
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Katherine Laiton-Donato, Carlos Franco-Muñoz, Diego A. Álvarez-Díaz, Hector Alejandro Ruiz-Moreno, José A. Usme-Ciro, Diego Andrés Prada, Jhonnatan Reales-González, Sheryll Corchuelo, María T. Herrera-Sepúlveda, Julian Naizaque, Gerardo Santamaría, Jorge Rivera, Paola Rojas, Juan Hernández Ortiz, Andrés Cardona, Diana Malo, Franklin Prieto-Alvarado, Fernando Ruiz Gómez, Magdalena Wiesner, Martha Lucia Ospina Martínez, Marcela Mercado-Reyes
medRxiv 2021.05.08.21256619; doi: https://doi.org/10.1101/2021.05.08.21256619

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1095)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9766)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1557)
  • Health Policy (734)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11639)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1175)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4654)
  • Radiology and Imaging (776)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)